Cite
HARVARD Citation
Sieuwerts, A. et al. (n.d.). Evaluation of the ability of adjuvant tamoxifen‐benefit gene signatures to predict outcome of hormone‐naive estrogen receptor‐positive breast cancer patients treated with tamoxifen in the advanced setting. Molecular oncology. 8 (8), pp. 1679-1689. [Online].